$SGMO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SANGAMO THERAPEUTICS, INC. Get notifications about new insider transactions in SANGAMO THERAPEUTICS, INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 16 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Sell | S | 13.48 | 10,000 | 134,786 | 218,160 | 228.2 K to 218.2 K (-4.38 %) |
| Apr 30 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Buy | M | 5.66 | 10,000 | 56,600 | 228,160 | 218.2 K to 228.2 K (+4.58 %) |
| Apr 23 2014 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Option Exercise | A | 14.20 | 10,000 | 142,000 | 10,000 | |
| Apr 23 2014 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Option Exercise | A | 14.20 | 10,000 | 142,000 | 10,000 | |
| Apr 23 2014 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Option Exercise | A | 14.20 | 10,000 | 142,000 | 10,000 | |
| Apr 23 2014 | SGMO | SANGAMO BIOSCIENCE ... | LARSON JOHN WILLIAM | Director | Option Exercise | A | 14.20 | 10,000 | 142,000 | 10,000 | |
| Apr 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 14.20 | 25,000 | 355,013 | 1,566,054 | 1.6 M to 1.6 M (-1.57 %) |
| Apr 23 2014 | SGMO | SANGAMO BIOSCIENCE ... | DILLY STEPHEN GEORGE | Director | Option Exercise | A | 14.20 | 10,000 | 142,000 | 10,000 | |
| Apr 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 7.73 | 13,000 | 100,490 | 37,000 | |
| Apr 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 15.74 | 2,000 | 31,476 | 225,347 | 227.3 K to 225.3 K (-0.88 %) |
| Apr 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 15.72 | 13,000 | 204,322 | 227,347 | 240.3 K to 227.3 K (-5.41 %) |
| Apr 11 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 7.73 | 13,000 | 100,490 | 240,347 | 227.3 K to 240.3 K (+5.72 %) |
| Apr 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Sr. VP Res. & CSO | Option Exercise | M | 5.35 | 5,000 | 26,750 | 90,000 | |
| Apr 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Sr. VP Res. & CSO | Option Exercise | M | 3.45 | 3,000 | 10,350 | 58,500 | |
| Apr 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Sr. VP Res. & CSO | Option Exercise | M | 13.98 | 4,000 | 55,920 | 82,000 | |
| Apr 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Sr. VP Res. & CSO | Option Exercise | M | 6.82 | 3,000 | 20,460 | 44,000 | |
| Apr 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Sr. VP Res. & CSO | Sell | S | 17.80 | 15,000 | 267,000 | 109,347 | 124.3 K to 109.3 K (-12.06 %) |
| Apr 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Sr. VP Res. & CSO | Buy | M | 5.35 | 5,000 | 26,750 | 124,347 | 119.3 K to 124.3 K (+4.19 %) |
| Apr 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Sr. VP Res. & CSO | Buy | M | 3.45 | 3,000 | 10,350 | 119,347 | 116.3 K to 119.3 K (+2.58 %) |
| Apr 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Sr. VP Res. & CSO | Buy | M | 13.98 | 4,000 | 55,920 | 116,347 | 112.3 K to 116.3 K (+3.56 %) |
| Apr 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Sr. VP Res. & CSO | Buy | M | 6.82 | 3,000 | 20,460 | 112,347 | 109.3 K to 112.3 K (+2.74 %) |
| Mar 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 4,000 | |
| Mar 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 13,000 | 44,850 | 140,000 | |
| Mar 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 18.64 | 2,000 | 37,283 | 97,015 | 99 K to 97 K (-2.02 %) |
| Mar 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 99,015 | 97 K to 99 K (+2.06 %) |
| Mar 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 19.10 | 200 | 3,820 | 97,015 | 97.2 K to 97 K (-0.21 %) |
| Mar 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 18.64 | 12,800 | 238,592 | 97,215 | 110 K to 97.2 K (-11.63 %) |
| Mar 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 13,000 | 44,850 | 110,015 | 97 K to 110 K (+13.40 %) |
| Mar 25 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | See Remarks | Option Exercise | M | 5.35 | 5,000 | 26,750 | 95,000 | |
| Mar 25 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | See Remarks | Option Exercise | M | 3.45 | 1,209 | 4,171 | 61,500 | |
| Mar 25 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | See Remarks | Option Exercise | M | 13.98 | 4,000 | 55,920 | 86,000 | |
| Mar 25 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | See Remarks | Option Exercise | M | 6.82 | 3,000 | 20,460 | 47,000 | |
| Mar 25 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | See Remarks | Option Exercise | M | 4.11 | 1,791 | 7,361 | 0 | |
| Mar 25 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | See Remarks | Sell | S | 22.38 | 15,000 | 335,763 | 109,347 | 124.3 K to 109.3 K (-12.06 %) |
| Mar 25 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | See Remarks | Buy | M | 5.35 | 5,000 | 26,750 | 124,347 | 119.3 K to 124.3 K (+4.19 %) |
| Mar 25 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | See Remarks | Buy | M | 3.45 | 1,209 | 4,171 | 119,347 | 118.1 K to 119.3 K (+1.02 %) |
| Mar 25 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | See Remarks | Buy | M | 13.98 | 4,000 | 55,920 | 118,138 | 114.1 K to 118.1 K (+3.50 %) |
| Mar 25 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | See Remarks | Buy | M | 6.82 | 3,000 | 20,460 | 114,138 | 111.1 K to 114.1 K (+2.70 %) |
| Mar 25 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | See Remarks | Buy | M | 4.11 | 1,791 | 7,361 | 111,138 | 109.3 K to 111.1 K (+1.64 %) |
| Mar 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Option Exercise | M | 5.03 | 10,000 | 50,300 | 40,000 | |
| Mar 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Sell | S | 23.26 | 10,000 | 232,608 | 0 | 10 K to 0 (-100.00 %) |
| Mar 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | Ramasastry Saira | Director | Buy | M | 5.03 | 10,000 | 50,300 | 10,000 | 0 to 10 K |
| Mar 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 5.19 | 50,000 | 259,500 | 0 | |
| Mar 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Gift | G | 0.00 | 4,000 | 0 | 1,591,054 | 1.6 M to 1.6 M (-0.25 %) |
| Mar 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 23.22 | 50,000 | 1,160,930 | 295,000 | 345 K to 295 K (-14.49 %) |
| Mar 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 5.19 | 50,000 | 259,500 | 345,000 | 295 K to 345 K (+16.95 %) |
| Mar 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Option Exercise | M | 3.87 | 9,722 | 37,624 | 0 | |
| Mar 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Sell | S | 22.77 | 6,103 | 138,955 | 23,563 | 29.7 K to 23.6 K (-20.57 %) |
| Mar 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | Mento Steven J | Director | Buy | M | 3.87 | 9,722 | 37,624 | 29,666 | 19.9 K to 29.7 K (+48.75 %) |
| Mar 12 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 182,000 | |
| Mar 12 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 22.31 | 10,000 | 223,071 | 227,347 | 237.3 K to 227.3 K (-4.21 %) |
| Mar 12 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 237,347 | 227.3 K to 237.3 K (+4.40 %) |
| Feb 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 6,000 | |
| Feb 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 13,000 | 44,850 | 153,000 | |
| Feb 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 19.73 | 2,000 | 39,452 | 97,015 | 99 K to 97 K (-2.02 %) |
| Feb 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 99,015 | 97 K to 99 K (+2.06 %) |
| Feb 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 19.72 | 13,000 | 256,300 | 97,015 | 110 K to 97 K (-11.82 %) |
| Feb 28 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 13,000 | 44,850 | 110,015 | 97 K to 110 K (+13.40 %) |
| Feb 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Option Exercise | M | 5.03 | 10,000 | 50,300 | 0 | |
| Feb 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Option Exercise | M | 6.05 | 15,000 | 90,750 | 35,000 | |
| Feb 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Sell | S | 18.06 | 25,000 | 451,575 | 800 | 25.8 K to 800 (-96.90 %) |
| Feb 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Buy | M | 5.03 | 10,000 | 50,300 | 25,800 | 15.8 K to 25.8 K (+63.29 %) |
| Feb 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Buy | M | 6.05 | 15,000 | 90,750 | 15,800 | 800 to 15.8 K (+1,875.00 %) |
| Feb 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 5.19 | 50,000 | 259,500 | 50,000 | |
| Feb 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 18.09 | 50,000 | 904,350 | 295,000 | 345 K to 295 K (-14.49 %) |
| Feb 19 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 5.19 | 50,000 | 259,500 | 345,000 | 295 K to 345 K (+16.95 %) |
| Feb 12 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 192,000 | |
| Feb 12 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 19.26 | 10,000 | 192,638 | 227,347 | 237.3 K to 227.3 K (-4.21 %) |
| Feb 12 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 237,347 | 227.3 K to 237.3 K (+4.40 %) |
| Jan 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 8,000 | |
| Jan 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 13,000 | 44,850 | 166,000 | |
| Jan 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 18.73 | 2,000 | 37,455 | 97,015 | 99 K to 97 K (-2.02 %) |
| Jan 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 99,015 | 97 K to 99 K (+2.06 %) |
| Jan 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 18.56 | 13,000 | 241,275 | 97,015 | 110 K to 97 K (-11.82 %) |
| Jan 29 2014 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 13,000 | 44,850 | 110,015 | 97 K to 110 K (+13.40 %) |
| Feb 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 4.11 | 7,000 | 28,770 | 1,791 | |
| Feb 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 3.45 | 8,000 | 27,600 | 62,709 | |
| Feb 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 18.83 | 15,000 | 282,516 | 109,347 | 124.3 K to 109.3 K (-12.06 %) |
| Feb 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 4.11 | 7,000 | 28,770 | 124,347 | 117.3 K to 124.3 K (+5.97 %) |
| Feb 05 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 3.45 | 8,000 | 27,600 | 117,347 | 109.3 K to 117.3 K (+7.32 %) |
| Jan 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 6.39 | 44,719 | 285,754 | 0 | |
| Jan 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 6.39 | 5,281 | 33,746 | 0 | |
| Jan 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 18.51 | 50,000 | 925,675 | 295,000 | 345 K to 295 K (-14.49 %) |
| Jan 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 6.39 | 44,719 | 285,754 | 345,000 | 300.3 K to 345 K (+14.89 %) |
| Jan 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 6.39 | 5,281 | 33,746 | 300,281 | 295 K to 300.3 K (+1.79 %) |
| Jan 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Option Exercise | M | 5.03 | 8,333 | 41,915 | 1,667 | |
| Jan 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Sell | S | 18.68 | 8,333 | 155,694 | 0 | 8.3 K to 0 (-100.00 %) |
| Jan 17 2014 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Buy | M | 5.03 | 8,333 | 41,915 | 8,333 | 0 to 8.3 K |
| Jan 14 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 202,000 | |
| Jan 14 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 18.69 | 10,000 | 186,893 | 227,347 | 237.3 K to 227.3 K (-4.21 %) |
| Jan 14 2014 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 237,347 | 227.3 K to 237.3 K (+4.40 %) |
| Jan 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 4.11 | 7,000 | 28,770 | 8,791 | |
| Jan 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 3.45 | 8,000 | 27,600 | 70,709 | |
| Jan 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 13.56 | 15,000 | 203,340 | 109,347 | 124.3 K to 109.3 K (-12.06 %) |
| Jan 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 4.11 | 7,000 | 28,770 | 124,347 | 117.3 K to 124.3 K (+5.97 %) |
| Jan 03 2014 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 3.45 | 8,000 | 27,600 | 117,347 | 109.3 K to 117.3 K (+7.32 %) |
| Dec 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 10,000 | |
| Dec 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 13,000 | 44,850 | 179,000 | |
| Dec 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 14.22 | 2,000 | 28,446 | 97,015 | 99 K to 97 K (-2.02 %) |
| Dec 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 2,000 | 10,380 | 99,015 | 97 K to 99 K (+2.06 %) |
| Dec 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 14.39 | 13,000 | 187,031 | 97,015 | 110 K to 97 K (-11.82 %) |
| Dec 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 13,000 | 44,850 | 110,015 | 97 K to 110 K (+13.40 %) |
| Dec 20 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 6.39 | 50,000 | 319,500 | 5,281 | |
| Dec 20 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 12.47 | 50,000 | 623,705 | 295,000 | 345 K to 295 K (-14.49 %) |
| Dec 20 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 6.39 | 50,000 | 319,500 | 345,000 | 295 K to 345 K (+16.95 %) |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | A | 12.12 | 70,000 | 848,400 | 70,000 | |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Payment of Exercise | F | 12.12 | 15,653 | 189,714 | 109,347 | 125 K to 109.3 K (-12.52 %) |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Grant | A | 0.00 | 35,000 | 0 | 125,000 | 90 K to 125 K (+38.89 %) |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | A | 12.12 | 46,000 | 557,520 | 46,000 | |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Payment of Exercise | F | 12.12 | 14,783 | 179,170 | 97,015 | 111.8 K to 97 K (-13.22 %) |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Grant | A | 0.00 | 23,000 | 0 | 111,798 | 88.8 K to 111.8 K (+25.90 %) |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | A | 12.12 | 150,000 | 1,818,000 | 150,000 | |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Payment of Exercise | F | 12.12 | 57,398 | 695,664 | 347,602 | 405 K to 347.6 K (-14.17 %) |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Grant | A | 0.00 | 75,000 | 0 | 405,000 | 330 K to 405 K (+22.73 %) |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Option Exercise | A | 12.12 | 70,000 | 848,400 | 70,000 | |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Payment of Exercise | F | 12.12 | 22,611 | 274,045 | 142,389 | 165 K to 142.4 K (-13.70 %) |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | NICHOL GEOFFREY | Executive Vice Pres ... | Grant | A | 0.00 | 35,000 | 0 | 165,000 | 130 K to 165 K (+26.92 %) |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | A | 12.12 | 70,000 | 848,400 | 70,000 | |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Payment of Exercise | F | 12.12 | 20,872 | 252,969 | 227,347 | 248.2 K to 227.3 K (-8.41 %) |
| Dec 13 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Grant | A | 0.00 | 35,000 | 0 | 248,219 | 213.2 K to 248.2 K (+16.42 %) |
| Dec 12 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 212,000 | |
| Dec 12 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 11.97 | 10,000 | 119,670 | 213,219 | 223.2 K to 213.2 K (-4.48 %) |
| Dec 12 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 223,219 | 213.2 K to 223.2 K (+4.69 %) |
| Dec 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 4.11 | 7,000 | 28,770 | 15,791 | |
| Dec 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 3.45 | 8,000 | 27,600 | 78,709 | |
| Dec 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 11.66 | 15,000 | 174,836 | 90,000 | 105 K to 90 K (-14.29 %) |
| Dec 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 4.11 | 7,000 | 28,770 | 105,000 | 98 K to 105 K (+7.14 %) |
| Dec 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 3.45 | 8,000 | 27,600 | 98,000 | 90 K to 98 K (+8.89 %) |
| Dec 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Option Exercise | M | 6.41 | 10,000 | 64,100 | 0 | |
| Dec 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Sell | S | 11.64 | 10,000 | 116,393 | 0 | 10 K to 0 (-100.00 %) |
| Dec 04 2013 | SGMO | SANGAMO BIOSCIENCE ... | Cleveland Paul B | Director | Buy | M | 6.41 | 10,000 | 64,100 | 10,000 | 0 to 10 K |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 3,000 | 15,570 | 12,000 | |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 2,000 | 6,900 | 192,000 | |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.61 | 10,000 | 36,100 | 0 | |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 11.83 | 3,000 | 35,476 | 88,798 | 91.8 K to 88.8 K (-3.27 %) |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 5.19 | 3,000 | 15,570 | 91,798 | 88.8 K to 91.8 K (+3.38 %) |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 11.83 | 12,000 | 141,902 | 88,798 | 100.8 K to 88.8 K (-11.90 %) |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 2,000 | 6,900 | 100,798 | 98.8 K to 100.8 K (+2.02 %) |
| Nov 29 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.61 | 10,000 | 36,100 | 98,798 | 88.8 K to 98.8 K (+11.26 %) |
| Nov 15 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 222,000 | |
| Nov 15 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 10.00 | 10,000 | 100,000 | 213,219 | 223.2 K to 213.2 K (-4.48 %) |
| Nov 15 2013 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 223,219 | 213.2 K to 223.2 K (+4.69 %) |
| Nov 15 2013 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 10.11 | 25,000 | 252,723 | 1,542,452 | 1.6 M to 1.5 M (-1.59 %) |
| Nov 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 4.11 | 7,000 | 28,770 | 22,791 | |
| Nov 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Option Exercise | M | 3.45 | 8,000 | 27,600 | 86,709 | |
| Nov 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 10.00 | 7,000 | 70,000 | 90,000 | 97 K to 90 K (-7.22 %) |
| Nov 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 4.11 | 7,000 | 28,770 | 97,000 | 90 K to 97 K (+7.78 %) |
| Nov 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Sell | S | 9.26 | 8,000 | 74,065 | 90,000 | 98 K to 90 K (-8.16 %) |
| Nov 05 2013 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | Vice President, Res ... | Buy | M | 3.45 | 8,000 | 27,600 | 98,000 | 90 K to 98 K (+8.89 %) |
| Oct 30 2013 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 5.19 | 3,000 | 15,570 | 15,000 |